Cogent Biosciences (COGT) Gross Profit: 2017-2020
Historic Gross Profit for Cogent Biosciences (COGT) over the last 4 years, with Sep 2020 value amounting to $312,000.
- Cogent Biosciences' Gross Profit fell 69.41% to $312,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $23.2 million, marking a year-over-year increase of 110.23%. This contributed to the annual value of $7.9 million for FY2020, which is 65.02% down from last year.
- Latest data reveals that Cogent Biosciences reported Gross Profit of $312,000 as of Q3 2020, which was down 40.91% from $528,000 recorded in Q2 2020.
- Cogent Biosciences' 5-year Gross Profit high stood at $15.3 million for Q4 2019, and its period low was $312,000 during Q3 2020.
- Moreover, its 3-year median value for Gross Profit was $2.2 million (2018), whereas its average is $3.6 million.
- In the last 5 years, Cogent Biosciences' Gross Profit soared by 301.79% in 2019 and then tumbled by 83.17% in 2020.
- Over the past 4 years, Cogent Biosciences' Gross Profit (Quarterly) stood at $2.1 million in 2017, then spiked by 79.23% to $3.8 million in 2018, then soared by 301.79% to $15.3 million in 2019, then slumped by 69.41% to $312,000 in 2020.
- Its Gross Profit stands at $312,000 for Q3 2020, versus $528,000 for Q2 2020 and $7.0 million for Q1 2020.